We report a case of fistula between the descending aorta and the left atrium with associated aortopulmonary window and secundum atrial septal defect. No previous reports of such association have been found in the literature. A 5-month-old infant presented with heart failure from the age of 2 weeks. Echocardiography confirmed the presence of an aorto-left atrial fistula, aortopulmonary window, and atrial septal defect. The diagnosis was additionally supported by computed tomography. The entity aorto-left atrial fistula is rare. It is mostly acquired and usually between the ascending aorta and the right atrium or right ventricle or left ventricle. We do not know about all the associated anomalies, which have implications in management. There is a case report of ascending aorto-left atrial fistula associated with bicuspid aortic valve and anomalous origin of coronaries. Here we are reporting a case of descending aorto-left atrial fistula associated with aortopulmonary window.
Even though infection with SARS-CoV-2 presents primarily with respiratory symptoms, unusual clinical manifestations have also been reported during the current pandemic. In May 2020, a middle-aged man presented to us with three episodes of impaired consciousness, which clinically appeared to be syncopal episodes. Patient had history of a single episode of mild fever 6 days prior to presentation, not accompanied by any respiratory symptoms. As a routine, swab for SARS-CoV-2 was sent and he tested positive. Holter recording was able to record sinus bradycardia followed by junctional escape during one such episode. Patient was managed symptomatically and there was no further recurrence of syncope.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.